Cultures treated with high glucose and BSO displayed a significantly lower growth rate, and cultures treated with IL1B showed a trend towards a higher growth rate, compared to the control [Glucose:0.14 PD/day, p<0.001, BSO: 0.11 PD/day, p = 0.006 and IL1B: 0.19 PD/day, p = 0.093 vs.
Cortical f in the CO of LOCM group reached the lowest value at 48-h ( p < 0.001) and showed a trend of recovery at 72-h ( p < 0.001).
The 35–44 years group showed a trend reversal in 2014 (APC = 1.90, 95% CI: 1.08–2.73; p < 0.001).
The variation in the number of daily meals showed a trend to decrease in patients with a short hospitalisation (3 nights and 4–15 nights, p < 0.001) and that was no longer significant in patients staying 16–30 nights ( p = 0.080) or more than 30 nights ( p = 0.444) at hospital.
Technology-supported treatments for depression showed a trend toward reduced depressive symptoms (SMD=–0.58, 95% CI –0.71 to –0.45; P <.001) ( Figure 4 ).
In the univariable model, preoperative serum albumin concentrations showed a trend for increasing the risk of AKI with decreasing serum albumin concentrations (OR = 0.960, 95%CI: 0.937–0.983, P = 0.001).
Patients with moderate and severe TR showed a trend towards a lower BMI (TR 0 29.8±5.5 kg/m 2 vs TR 1 27.9±4.9 kg/m 2 , TR 2 26.7±5.1 kg/m 2 and TR 3 26.9±5.0; p<0.001).
Additional analysis showed a trend toward increased neck and wrist circumference among participants adhering to this pattern (β = 1.12, P < .001; β = .71, P = .001, respectively).
Moreover, in patients diagnosed with acute coronary syndrome (ACS), higher TyG index levels showed a trend of increased risk of MACE (HR = 1.54; 95% CI: 1.27–1.86; P < 0.001).
Consistently, DIRAS3 and FOSB showed a trend of downregulation in MM patients relative to normal subjects (P < 0.001), whereas the other genes showed the opposite trend (P < 0.001) ( Figure 12 ). 4.
In our cohort, higher baseline CRP was significantly associated with higher baseline EED in the unifactorial analysis but only showed a trend when adjusting for confounders ( p < 0.001 and p = 0.055, respectively).
For both boys and girls, the incidence of nonfatal injuries showed a trend to decrease with increasing age or grade (Cochran-Armitage trend test, P <0.001; Table 1 ).
Subgroup analysis showed a trend that reduced PTEN levels were associated with the following factors: depth of invasion (12 studies, 1599 patients; OR = 2.604, 95% CI = 1.554–4.366, P<0.001); lymph node metastasis (18 studies, 2258 patients; OR = 2.484, 95% CI = 1.836–3.360, P<0.001); distant metastasis (9 studies, 1393 patients;
Specifically, LTRs with infection showed a trend toward reduced α-diversity ( Fig. 5 A) and pronounced shifts in β-diversity ( P = 0.001; Fig. 5 B), reflecting a distinct microbial community composition.
Whereas age ( P = 0.001), BMI ( P = 0.001), BUN ( P < 0.001), Scr ( P < 0.001), Alb ( P = 0.005) and TG ( P < 0.001) showed a trend of increasing across the SUA quartiles in the female, eGFR ( P < 0.001), HDL-c ( P < 0.001), LDL-c ( P = 0.009), FBG ( P < 0.001), 2h-PG ( P < 0.001) and HbA1c% ( P < 0.001) were significantly decreased with ascending SUA quartiles Correlations between SUA and clinical characteristics by gender As
The Ne in the present study was maximal at Cz; the amplitude difference between ERPs to errors and to correct trials tested at this electrode (where the Ne was largest) was highly significant, F (1,14) = 129.9, p < .001, and also showed a trend for an interaction between group, session, and correctness, F (1,14) = 3.8, p = .073.
Analysis of adherence issues in relation to patient age showed a trend toward worse adherence to capecitabine therapy in the group of patients aged ≥80 years (hazard ratio =3.83; 95% confidence interval 2.48–5.91, P <0.001 versus 70–80 years group and versus <70 years group, chi-square test).
TIPS showed a trend toward lower variceal re-bleeding (RR = 0.46, 95% CI = 0.36–0.58, P < 0.001), but a higher incidence of hepatic encephalopathy than ET (RR = 1.78, 95% CI = 1.34–2.36, P < 0.001).
After drug intervention, CCr showed a trend of improvement, especially in the combination therapy group ( P <0.001) ( Figure 2C ).
LBF adhesive also showed a trend similar to that of the FL bond; the released fluoride reduced from day 1 until day 28 ( p ≤0.001).
In the CSA 25° and 30° groups, the total intersection volume showed a trend of increasing and then decreasing with the increasing value of CPA ( r = 0.111, p < 0.001).
Except for the ≥ 100 years old group, BMI in other age groups also showed a trend of increasing with the years (p < 0.001) in Fig. 2 B.
( 13 ) who state that the preoperative outcomes in the second period of surgeries [2016–2018]showed a trend towards better performance than in the first period [2013–2015], with shorter hospital (6.34±2.84 vs. 9.50±6.37 days, P<0.001), and ICU stays (1.15±0.59 vs. 1.94±2.08 days), and decreasing complication rates (19.40% vs. 45.80%, P=0.001), with an advantage in oncological results: 3-year OS of 73.5% [95% confidence interval (CI): 65.0–83.1%] vs. 57.4% (95% CI: 44.8–73.5%; P=0.047).
Doctors’ attitude showed a trend similar to the overall completeness, while nurses improved more consistently (p<0.001).
By vaccine type: PCV7 (RR = 0.89, 95% CI: 0.74–1.06) and PCV10 (RR = 0.56, 95% CI: 0.08–3.95) showed a trend toward a lower incidence of AOM compared with controls, whereas PCV13 + PCV10 (RR = 3.00, 95% CI: 2.91–3.10, p < 0.001) and PCV13 (RR = 1.20, 95% CI: 1.05–1.37, p = 0.007) were associated with a significantly higher incidence of AOM (Figure S4 ).